Graeme Wald

Experienced Director, Chairman and CEO with a demonstrated history of working in the capital markets industry and managing Life Science companies. Skilled in Financial Risk Management (Chairman of Audit & Risk Committee), Investment Funds and managing Life Science companies. Strong professional achievements demonstrated by restructuring and re-capitalising companies. Listed five companies on the ASX while at Wilson HTM and raised approximately $750M in primary and secondary offerings.
I have worked with companies developing technologies that include analgesics, monoclonal antibodies, skin repair systems, cystic fibrosis, cardiac assist devices, sterilisation and disinfection and anaesthesia.